首页 正文

Meta-Analysis Journal of the American Heart Association. 2020 Apr 7;9(7):e015323. doi: 10.1161/JAHA.119.015323 Q15.32025

Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis

二甲双胍联合GLP-1受体激动剂和SGLT-2抑制剂降糖减重对2型糖尿病患者血压影响的meta分析 翻译改进

Mengdie Hu  1, Xiaoling Cai  1, Wenjia Yang  1, Simin Zhang  1, Lin Nie  2, Linong Ji  1

作者单位 +展开

作者单位

  • 1 Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China.
  • 2 Department of Endocrinology and Metabolism Beijing Airport Hospital Beijing China.
  • DOI: 10.1161/JAHA.119.015323 PMID: 32223390

    摘要 Ai翻译

    Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) have shown their beneficial effects on cardiovascular outcomes and multiple cardiovascular risk factors, including hypertension. However, the mechanism of blood pressure (BP)-lowering effects of these agents has not been elucidated. This study aims to evaluate the effect of hemoglobin A1c reduction or body weight reduction with GLP-1RA tr... ...点击完成人机验证后继续浏览
    Copyright © Journal of the American Heart Association. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Journal of the american heart association

    缩写:J AM HEART ASSOC

    ISSN:N/A

    e-ISSN:2047-9980

    IF/分区:5.3/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis